QNCX Quince Therapeutics

Watchlist

1.930
+0.180+10.29%

Close Dec 27 16:00 ET

1.940
+0.010+0.52%

Post 16:32 ET

84.92MMarket Cap-1.56P/E (TTM)

About Quince Therapeutics Company

Quince Therapeutics, Inc.(formerly Cortexyme, Inc.） is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Company Profile

SymbolQNCX

Company NameQuince Therapeutics

Listing DateMay 9, 2019

Founded2012

CEOMr. Dirk Thye, M.D.

MarketNASDAQ

Employees32

Fiscal Year Ends12-31

Address611 Gateway Boulevard,Suite 273

CitySouth San Francisco

ProvinceCalifornia

CountryUnited States of America

Zip Code94080

Phone1-650-910-5717

Websitehttp://quincetx.com

Company Executives

Name
Position
Salary

Dirk Thye, M.D.
Chief Executive Officer, Chief Medical Officer and Director
1.33M

Brendan Hannah
Chief Operating Officer, Chief Compliance Officer, Chief Business Officer, Principal Financial Officer and Principal Accounting Officer
847.50K